Indazole compounds and their uses

Details for Australian Patent Application No. 2011227643 (hide)

Owner Dana-Farber Cancer Institute, Inc.

Inventors Gray, Nathanael; Zhou, Wenjun; Deng, Xianming

Agent Spruson & Ferguson

Pub. Number AU-A-2011227643

PCT Pub. Number WO2011/115725

Priority 61/314,402 16.03.10 US

Filing date 18 February 2011

Wipo publication date 22 September 2011

International Classifications

C07D 231/56 Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/416 - condensed with carbocyclic ring systems, e.g. indazole

A61K 31/4178

A61K 31/454

A61K 31/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 35/00 Antineoplastic agents

C07D 401/10 Heterocyclic compounds containing two or more hetero rings

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

20 September 2012 PCT application entered the National Phase

  PCT publication WO2011/115725 Priority application(s): WO2011/115725

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011227644-Vendor

2011227642-Photocatalyst comprising TiO2 and activated carbon made from date pits